Concepedia

Publication | Closed Access

SLV313 is a dopamine D2 receptor antagonist and serotonin 5-HT1A receptor agonist: In vitro and in vivo neuropharmacology

DOI

10

Citations

0

References

2002

Year

Jeffrey Glennon, Andrew C. McCreary, Eric Ronken, Richard J. Siarey, M.B. Hesselink, R. Feenstra, B. Van Vliet, S.K. Long, C.G. Kruse
European Neuropsychopharmacology

No additional data available for this publication yet. Check back later!